Intuitive Surgical, Inc. $ISRG Stock Bought by Legacy Wealth Asset Management LLC

Legacy Wealth Asset Management LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.9% in the third quarter, Holdings Channel reports. The institutional investor owned 4,857 shares of the medical equipment provider’s stock after buying an additional 1,876 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Intuitive Surgical were worth $1,975,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ISRG. North Point Portfolio Managers Corp OH bought a new position in Intuitive Surgical during the 3rd quarter valued at $27,000. Main Street Group LTD acquired a new position in Intuitive Surgical during the 1st quarter worth $30,000. Compass Financial Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $30,000. Vermillion Wealth Management Inc. increased its position in shares of Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $34,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $415.41 on Friday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company has a 50-day simple moving average of $384.95 and a 200-day simple moving average of $411.17. The firm has a market capitalization of $146.76 billion, a PE ratio of 47.58, a price-to-earnings-growth ratio of 3.13 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the prior year, the business earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. TD Cowen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Truist Financial cut their price objective on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, September 20th. Finally, Barclays upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $502.53.

Insider Activity at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director owned 251 shares in the company, valued at $95,129. The trade was a 61.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by insiders.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays initiated coverage with an Overweight rating and later upgraded the stock to Strong Buy, signaling confidence in Intuitive Surgical’s market position and long-term growth prospects. Barclays starts coverage of Intuitive Surgical stock at Overweight
• Positive Sentiment: Piper Sandler also rated ISRG Buy, adding to the cluster of bullish opinions from Wall Street analysts. Intuitive Surgical gets a Buy from Piper Sandler
• Positive Sentiment: Intuitive Surgical’s single-port robotic platform is gaining traction, with rising procedure volumes, utilization and system placements, as well as expanding indications and international adoption. That platform could become a major additional growth franchise. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts’ average recommendation remains bullish, but commentary cautions that sell-side ratings can be overly optimistic and should not be treated as a standalone investment signal. Investors are focused on the upcoming earnings release, which is expected to show year-over-year revenue and earnings growth. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: Competition is becoming a larger concern. Jim Cramer highlighted Johnson & Johnson and other entrants as threats, while investors continue to debate whether ISRG’s premium valuation adequately reflects its strong competitive position and recurring-revenue model. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.